Reports for SITAGLIPTIN

Ingredient

SITAGLIPTIN

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-SITAGLIPTIN/METFORMIN XR 500MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2024-02-02 185970
APO-SITAGLIPTIN/METFORMIN XR 1000MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-16 2023-01-09 178772
APO-SITAGLIPTIN/METFORMIN XR 1000MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-16 2023-01-20 178775
APO-SITAGLIPTIN/METFORMIN XR 1000MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2024-02-02 185973
APO-SITAGLIPTIN/METFORMIN XR 1000MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2024-02-02 185976
APO-SITAGLIPTIN/METFORMIN XR 1000MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2024-02-02 185982
APO-SITAGLIPTIN/METFORMIN XR 1000MG 100MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2024-02-02 185967
APO-SITAGLIPTIN/METFORMIN XR 1000MG 100MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2024-02-02 185985
JANUMET XR 500MG 50MG TABLET (EXTENDED-RELEASE) Avoided shortage 2022-03-25 2022-04-18 157343
JANUMET XR 1000MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2021-12-08 2021-12-14 150734

Showing 1 to 10 of 58

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
STEGLUJAN 5MG 100MG TABLET Discontinued 2021-02-04 2021-02-04 133310
STEGLUJAN 15MG 100MG TABLET Discontinued 2021-02-04 2021-02-04 133307

Showing 1 to 2 of 2